CERTOLIZUMAB PEGOL

CERTOLIZUMAB PEGOL (12027B)

certolizumab pegol 200 mg/mL injection, 2 x 1 mL pen devices
12027B
Body System:
Manner of administration:Injection
General Schedule
Authority Required

Restriction

Indication: Non-radiographic axial spondyloarthritis
Treatment phase: Initial treatment - Initial 1 (New patient)

Restriction

Indication: Non-radiographic axial spondyloarthritis
Treatment phase: Initial treatment - Initial 2 (Change or re-commencement of treatment after a break in biological medicine of less than 5 years)

Restriction

Indication: Non-radiographic axial spondyloarthritis
Treatment phase: Initial treatment - Initial 3 (Recommencement of treatment after a break in biological medicine of more than 5 years)
Quantities & Cost
Max qty packs Max qty units # of repeats DPMQ Max safety net General Patient Charge
Max qty packs: 3 Max qty units: 6 # of repeats: 0 DPMQ: $2,977.05 Max safety net: $25.00 General Patient Charge: $25.00
Available brands
Cimzia